Odyssey Therapeutics, Inc. · NASDAQ:ODTX
Glick Gary D converted 27,386 Odyssey Therapeutics, Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 11, 2026
On May 11, 2026, Glick Gary D (Director, See Remarks) converted 27,386 Odyssey Therapeutics, Inc. shares, leaving 415,973 shares. Filed May 11, 2026 (Form 4).
- Converted
- 27,386 shares
- Holding after
- 415,973 shares
- Trading plan
- No
- Role
- Director, See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Conversion | 27,386 | 415,973 | Direct |
Source
Related
- Odyssey Therapeutics, Inc.
- Glick Gary D
- Odyssey Therapeutics, Inc. shareholders
- Schedule 13G · FMR LLC · Jun 5, 2026
- Schedule 13D · SR One Capital Management, LLC · May 18, 2026
- Schedule 13D · Tpg Gp A, LLC · May 18, 2026
- Schedule 13G · Lightspeed Venture Partners XV-B (Ignite), L.P. · May 18, 2026
- Schedule 13D · Jeito II S.L.P. · May 15, 2026